Skip Navigation

Drug Research and Price Controls

December 1, 2002
By John A. Vernon

This article argues the pros and cons as to whether or not the U.S. government should join the bandwagon of the rest of the world by regulating prescription drug costs.

stethoscope and insurance docs

This article argues the pros and cons as to whether or not the U.S. government should join the bandwagon of the rest of the world by regulating prescription drug costs.  He writes:

The striking difference has given rise to one of the most contentious public policy issues in recent years: whether or not the U.S. government should join most of the rest of the world in regulating drug prices.  In general, supporters of pharmaceutical price controls argue that drug prices in the United States are excessive and that price controls would ensure affordable health care for all Americans.  Opponents of the price regulation argue that price controls would significantly diminish incentives to invest in pharmaceutical research and development, which would harm medical advances in the future.

Article Tags
Health Care